Profile
ALUR ABT BSX-PA BSX SYK MDT
Company Name Allurion Technologies Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $14.20M $215.16B $175.45B $149.24B $141.06B $116.34B
Employees 0.13K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Shantanu K. Gaur Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
ALUR ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
ALUR ABT BSX-PA BSX SYK MDT
Last Close $1.85 $123.62 $122.18 $100.72 $356.24 $90.7
High 52 $8.87 $140.22 $122.18 $108.14 $403.53 $98.43
Low 52 $0.28 $111.1 $122.18 $83.62 $337.28 $79.61
Price vs. 52 Week High -79.14 % -11.84 % 0 % -6.86 % -11.72 % -7.85 %
Price vs. 52 Week Low 560.71 % 11.27 % 0 % 20.45 % 5.62 % 13.93 %
Total Return
ALUR ABT BSX-PA BSX SYK MDT
1 Month Return -8.87 % -7.38 % 0 % 5.08 % -2.19 % -4.33 %
3 Month Return -32.97 % -2.88 % 0 % -4.45 % -5.7 % 1.52 %
6 Month Return -20.6 % -5.55 % 0 % -2.39 % -4.75 % 8.54 %
9 Month Return -68.54 % -3.37 % 0 % -1.6 % -8.96 % -0.13 %
YTD Return 330.23 % 9.29 % 0 % 12.76 % -1.06 % 13.55 %
1 Year Return 160.93 % 4.23 % 0 % 20.45 % -2.97 % 0.7 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALUR ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.91 % - - 0.91 % 3.11 %
Dividend Paid and Capex Coverage Ration (TTM) -580.82 % 1.45 % 4.3 % 4.3 % 2.39 % 1.31 %
Dividend Per Share (TTM) - 2.36 % - - 3.36 % 2.82 %
Payout Ratio (TTM) - 28.42 % 0.82 % 0.82 % 42.87 % 77.26 %
Growth
ALUR ABT BSX-PA BSX SYK MDT
Asset Growth -54.24 % 11.2 % 12.12 % 1.89 %
Gross Profit Growth -48.18 % 6.43 % 16.26 % 3.58 %
Revenue Growth -39.94 % 4.59 % 17.61 % 3.62 %
Revenue 3 Year -68.57 % -0.18 % 36.16 % 10.52 %
Revenue 5 Year - 34.24 % 47.52 % 20.96 %
Revenue 10 Year - 80.43 % 104.22 % 41.05 %
EBIT Growth 66.8 % 3.45 % 18.25 % 14.42 %
Net Income Growth 67.56 % 134.18 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 20.97 % 94.27 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -24269705.29 % 271.11 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share -24269705.29 % 410.99 % 1502.13 % 48.51 %
Operating Income Growth 36.52 % 6.06 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 33.89 % 17.86 % 37.24 % 3.79 %
Operating 3 Year CFG -10.51 % -16.72 % 77.55 % 0.13 %
Operating 5 Year CFG -5798379864.38 % 42.4 % 76.92 % 1.55 %
Operating 10 Year CFG -5798379864.38 % 102.79 % 143.61 % 22.45 %
EPS Growth 79.87 % 132.42 % 16.61 % 31.05 %
EPS Diluted Growth 79.87 % 133.64 % 16.52 % 30.8 %
Book Value Per Share 31.38 % 23.54 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share 14.86 % 36.46 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share -18865317.89 % 56.53 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share -18865317.89 % 92.83 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - 128.74 %
Debt Growth -9.4 % -3.77 % 17.44 % 13.95 %
Free Cash Flow Growth 34.57 % 25.54 % 55.31 % -0.29 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
ALUR ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 61.77 % 52.79 % 65.05 % 65.05 % 62.19 % 63.44 %
Return on Assets TTM -143.45 % 16.64 % 6.71 % 6.71 % 6.3 % 5.12 %
Return on Equity TTM 58.66 % 29.93 % 12.8 % 12.8 % 14.08 % 9.62 %
Return on Capital Employed TTM -263.94 % 10.7 % 9.22 % 9.22 % 13.86 % 7.71 %
Net Income Per EBT TTM 101.8 % 176.99 % 85.26 % 85.26 % 87.08 % 82.32 %
EBT Per Ebit TTM 90.85 % 104.64 % 97.5 % 97.5 % 61.93 % 92.49 %
EBIT Per Revenue TTM -219.36 % 17.51 % 17.33 % 17.33 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -137 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Receivables Turnover TTM 3.41 4.21 6.87 6.87 6.08 5.46
Payables Turnover TTM 1.99 4.73 7.03 7.03 6.25 4.89
Inventory Turnover TTM 2.02 2.93 2.36 2.36 1.7 -33.52
Fixed Asset Turnover TTM 540.34 % 378.32 % 489.63 % 489.63 % 560.03 % -6785.71 %
Asset Turnover TTM 70.71 % 51.32 % 46.56 % 46.56 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -0.57 5.19 2.89 2.89 12.47 5.58
Free Cash Flow Per Share TTM -0.57 3.89 2.23 2.23 10.53 4.14
Cash Per Share TTM 17.43 % 418.4 % 36.04 % 36.04 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -209.97 % 20.96 % 22.14 % 22.14 % 20.01 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.17 % 74.97 % 77.27 % 77.27 % 84.43 % 74.21 %
Cash Flow Coverage Ratios TTM -137 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Price To Free Cash Flows Ratio TTM -0.34 31.76 44.89 45.07 35.06 21.94
Price To Operating Cash Flows Ratio TTM -3.19 23.81 34.68 34.83 29.59 16.27
Price Cash Flow Ratio TTM -3.19 23.81 34.68 34.83 29.59 16.27
Income Statement (TTM)
ALUR ABT BSX-PA BSX SYK MDT
Revenue $0.03B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0.02B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 66.97% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.02B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.03B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -11.64 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
ALUR ABT BSX-PA BSX SYK MDT
Long Term Debt $0.04B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0.11B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $-0.08B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0.04B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.03B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
ALUR ABT BSX-PA BSX SYK MDT
Net Income $-0.03B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.04B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 123.62
ADGM Adagio Medical Holdings, Inc. 1.14
AEMD Aethlon Medical, Inc. 5.26
AFIB Acutus Medical, Inc. 0.0003
AHCO AdaptHealth Corp. 8.99
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 137.88
AMIX Autonomix Medical, Inc. Common Stock 1.03
ANIK Anika Therapeutics, Inc. 9.75
AORT Artivion, Inc. 45.37
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 3.03
ARAY Accuray Incorporated 1.41
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 18.99
AVNS Avanos Medical, Inc. 11.11
AVR Anteris Technologies Global Corp. Common Stock 4.49
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 22.22
ETFs With Exposure to ALUR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 335.42
VXF Vanguard Extended Market Index Fund 0.0001 211.74
IWC iShares Micro-Cap ETF 0.0004 156.22
JSML Janus Henderson Small Cap Growth Alpha ETF 0.01 74.3809
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 53.28
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 53.27
VBINX Vanguard Balanced Index Fund Investor Shares 0 53.27
VTSAX Vanguard Total Stock Market Index Fund 0 163.24
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0001 160.7
VITSX Vanguard Total Stock Market Index Fund 0 163.27
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0001 160.71
VEMPX Vanguard Extended Market Index InstlPlus 0.0001 396.57
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 306.27
Unlock